BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $435 | -100.0% | 9,663 | -66.0% | 0.01% | -82.5% |
| Q3 2022 | $1,874,000 | +97.3% | 28,444 | +51.3% | 0.04% | +60.0% |
| Q2 2022 | $950,000 | +47.1% | 18,805 | +86.1% | 0.02% | +66.7% |
| Q1 2022 | $646,000 | -23.2% | 10,105 | +28.7% | 0.02% | +7.1% |
| Q4 2021 | $841,000 | -25.4% | 7,852 | -28.4% | 0.01% | -22.2% |
| Q3 2021 | $1,127,000 | -84.2% | 10,960 | -86.5% | 0.02% | -86.7% |
| Q2 2021 | $7,148,000 | +795.7% | 81,259 | +667.9% | 0.14% | +575.0% |
| Q4 2017 | $798,000 | +196.7% | 10,582 | +173.7% | 0.02% | +185.7% |
| Q3 2017 | $269,000 | -5.6% | 3,866 | -31.2% | 0.01% | -22.2% |
| Q2 2017 | $285,000 | -84.5% | 5,617 | -87.8% | 0.01% | -84.2% |
| Q1 2017 | $1,838,000 | +53.9% | 45,961 | +8.0% | 0.06% | +83.9% |
| Q4 2016 | $1,194,000 | +328.0% | 42,559 | +352.6% | 0.03% | +342.9% |
| Q3 2016 | $279,000 | – | 9,403 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |